Immetas Therapeutics is Drug Discovery in United States that focus on inflammatory diseases business. Founded in 2018. They cover business area such as developer, novel therapeutic, age-relate cancer, inflammatory disease, emerge evidence, chronic low-grade inflammation, aging and age-relate disease, clinical evidence, development risk, healthcare professional, osteoarthritis.
2018
( 6 years old in 2024 )
Inflammatory Diseases
-
120 Eagle Rock Avenue
Suite 141
East Hanover, NJ 07936
United States
Private
developernovel therapeuticage-relate cancerinflammatory diseaseemerge evidencechronic low-grade inflammationaging and age-relate diseaseclinical evidencedevelopment riskhealthcare professionalosteoarthritis
* We use standard office opening hours in near Immetas Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Immetas Therapeutics is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), Immetas Therapeutics business is focusing on Inflammatory Diseases.
Immetas Therapeutics headquarter office and corporate office address is located in 120 Eagle Rock Avenue Suite 141 East Hanover, NJ 07936 United States.
Immetas Therapeutics was founded in United States.
In 2024, Immetas Therapeutics is currently focus on inflammatory diseases sector.
Above is snippet of Google Trends for "inflammatory diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Immetas Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
